Capillary Leak Index Versus Conventional Biomarkers in Predicting Sepsis-Related Outcomes (NCT07232342) | Clinical Trial Compass
RecruitingNot Applicable
Capillary Leak Index Versus Conventional Biomarkers in Predicting Sepsis-Related Outcomes
Egypt100 participantsStarted 2025-12-10
Plain-language summary
This study aims to evaluate the prognostic significance of CLI in predicting 28-day mortality and other outcomes in critically ill patients who develop post-operative abdominal sepsis.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Age ≥ 18 years.
Postoperative secondary peritonitis requiring ICU admission, with clinical evidence of:
Diffuse or localized abdominal pain/tenderness. Peritoneal signs (e.g., guarding, rigidity, rebound tenderness). Imaging or intraoperative confirmation of purulent/exudative intra-abdominal fluid.
Systemic inflammation (e.g., fever, leukocytosis, or vasopressor requirement). Sepsis diagnosis per Sepsis-3 criteria: Suspected/confirmed infection with acute increase in SOFA score ≥2 points (6).
Anticipated ICU stay ≥48 hours postoperatively.
Exclusion Criteria:
* Pregnancy
* Advanced liver disease (Child-Pugh class B or C) that might independently affect albumin levels
* Advanced kidney disease (CKD stage 4 or 5) or patients on chronic dialysis
* Expected mortality within 48 hours of ICU admission
* Patients with primary peritonitis or tertiary peritonitis
* Immunocompromised patients (e.g., on chronic immunosuppressive therapy, solid organ transplant recipients, patients with HIV and CD4 count \<200/mm³)
* Patients with pre-existing systemic inflammatory diseases that might affect baseline CRP levels
* Patients participating in interventional trials that might affect outcomes